Literature DB >> 10573524

Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice.

A B Lentsch1, H Yoshidome, A Kato, R L Warner, W G Cheadle, P A Ward, M J Edwards.   

Abstract

Hepatic ischemia and reperfusion causes neutrophil-dependent liver injury. Although the mechanisms of ischemia/reperfusion-induced liver neutrophil recruitment are somewhat understood, less is known regarding the early events that initiate the inflammatory injury. Using a murine model of partial hepatic ischemia and reperfusion, we evaluated the role of endogenous interleukin (IL)-12 in this inflammatory response. Hepatic ischemia for 90 minutes and reperfusion for up to 4 hours resulted in hepatocyte expression of IL-12. By 8 hours of reperfusion there were large increases in serum levels of interferon-gamma (IFNgamma) and tumor necrosis factor-alpha (TNFalpha). In addition, hepatic ischemia/reperfusion caused significant increases in liver neutrophil recruitment, hepatocellular injury, and liver edema, as defined by liver myeloperoxidase content, serum alanine aminotransferase, and liver wet to dry weight ratios, respectively. In mice treated with neutralizing antibody to IL-12 and in mice deficient in the IL-12 p40 gene, ischemia/reperfusion-induced increases in IFNgamma and TNFalpha were greatly diminished. These conditions also caused significant reductions in liver myeloperoxidase content and attenuated the parameters of liver injury. The data suggest that IL-12 is required for the full induction of injury after hepatic ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573524     DOI: 10.1002/hep.510300615

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Ritha M Belizaire; Ralph Cutler Quillin; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 4.029

2.  CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.

Authors:  Gregory C Wilson; Christopher M Freeman; Joshua W Kuethe; Ralph C Quillin; Hiroyuki Nojima; Rebecca Schuster; John Blanchard; Michael J Edwards; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-02-26       Impact factor: 4.052

3.  Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway.

Authors:  Mona F Mahmoud; Shimaa M El Shazly; Waleed Barakat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-08       Impact factor: 3.000

4.  STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia.

Authors:  A B Lentsch; A Kato; B Davis; W Wang; C Chao; M J Edwards
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver.

Authors:  Hannes A Rüdiger; Koo J Kang; David Sindram; Hans M Riehle; Pierre A Clavien
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

6.  Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2012-01-13       Impact factor: 17.425

7.  Role of nitric oxide in liver ischemia and reperfusion injury.

Authors:  Ian N Hines; Shigeyuki Kawachi; Hirohisa Harada; Kevin P Pavlick; Jason M Hoffman; Sulaiman Bharwani; Robert E Wolf; Matthew B Grisham
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Cortical spreading depression modifies components of the inflammatory cascade.

Authors:  Charlie S Thompson; Antoine M Hakim
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

9.  Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Authors:  Zubin M Bamboat; Vinod P Balachandran; Lee M Ocuin; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 10.  CXC chemokines play a critical role in liver injury, recovery, and regeneration.

Authors:  Callisia N Clarke; Satoshi Kuboki; Amit Tevar; Alex B Lentsch; Michael Edwards
Journal:  Am J Surg       Date:  2009-09       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.